Effect of shilajit on blood glucose and lipid profile in alloxan-induced diabetic rats

Indian Journal of Pharmacology

Volumn 36, Issue 6, 2004, Pages 373-376

  Trivedi, N A ^a   Mazumdar, B ^a   Bhatt, J D ^a   Hemavathi, K G ^a  

^a Baroda Medical College   (India)

Author keywords

Biguanide; Diabetis mellitus; Herbomineral antidiabetic; Sulfonylurea

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLUCOSE; LIPID; METFORMIN; SHILAJEET;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; METABOLIC PARAMETERS; NONHUMAN; RAT;

EID: 14944382897     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Halliwell B, Gutteridge JMC. Free radicals in Biology and Medicine. 2nd Ed. Oxford: Clarendon Press; 1989.
2. Ghosal S, Reddy JP, Lal VK. Shilajit Part 1 - Chemical constituents. J Pharm Sci 1976;65:772-3.
3. Ghosal S. Shilajit Part 7- Chemistry of Shilajit, an immunomodulatory ayurvedic rasayana. Pure Appl Chem (IUPAC) 1990;62:1285-8.
4. Ghosal S, Lal J, Singh SK, The core structure of Shilajit humus. Soil Biol Biochem 1992;23:673-80.
5. Tiwari VP, Tiwari KC, Joshi PJ. An interpretation of Ayurvedika findings on Shilajit. J Res Indigenous Med 1973;8:57.
6. Gupta SS. Effect of Shilajit, Ficus Bengalensis & ant. Pituitary extract on glucose tolerance in rats. Indian J Med Res 1966;54:354-66.
7. Bhattacharya SK. Shilajit attenuates streptozotocin induced DM & decrease in pancreatic islet superoxide dismutase activity in rats. Phytother Res 1995;9:41-4.
8. Bhattacharya SK, Sen AP. Effect of shilajit on biogenic free radicals. Phytother Res 1995;9:56-9.
9. Ghosal S, Soumya L, Kumar Y. Interaction of Shilajit with biogenic free radicals. Indian J Chem 1995;34B:596-602.
10. Austin MA, Hokanson JE. Epidemiology of triglyceride, small dense low-density lipoprotein and lipoprotein(a) as risk factors for coronary heart disease. Med Clin North Am 1994;78:99-115.
11. Kraus-Friedmann N. Hormonal regulation of hepatic gluconeogenesis. Physiol Rev 1984;64:170-6.
12. Brown MS, Goldstein JL. Lipoprotein receptor in the liver. Control signals for plasma cholesterol traffic. J Clin Invest 1983;72:743-7.
13. Chehade JM, Mooradian. A rational approach to drug therapy of type-2 diabetes mellitus. Drugs 2000;60:95-113.
14. Defronzo RA, Goodman AM. Efficacy of metformin in patient with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:541-9.